Manuel Romero-Gomez Selected Research

selonsertib

1/2022	Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials.
1/2022	Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis.
1/2020	Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials.
11/2019	Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials.
11/2019	Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manuel Romero-Gomez Research Topics

Disease

23	Fibrosis (Cirrhosis) 10/2022 - 11/2011
19	Non-alcoholic Fatty Liver Disease 10/2022 - 08/2015
9	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 03/2015
9	Infections 01/2021 - 04/2011
7	Liver Diseases (Liver Disease) 10/2022 - 05/2009
6	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2015
5	Chronic Hepatitis C 01/2019 - 04/2011
5	Chemical and Drug Induced Liver Injury 07/2011 - 12/2006
4	Inflammation (Inflammations) 01/2022 - 01/2016
4	Hepatic Encephalopathy 01/2020 - 04/2006
4	Insulin Resistance 01/2016 - 11/2011
3	Hemorrhage 01/2021 - 07/2013
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2016
3	Fatty Liver 11/2020 - 08/2015
3	Acute Liver Failure (Fulminant Hepatic Failure) 06/2009 - 08/2005
2	Fatigue 10/2022 - 11/2020
2	Pruritus (Itching) 11/2021 - 11/2020
2	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2021
2	Alcoholic Fatty Liver 01/2020 - 01/2020
2	Neoplasms (Cancer) 01/2018 - 01/2016
2	Weight Loss (Weight Reduction) 01/2016 - 08/2015
2	Vitamin D Deficiency 07/2015 - 09/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2015 - 11/2011
2	Esophageal and Gastric Varices (Esophageal Varices) 11/2013 - 07/2013
2	Jaundice (Icterus) 10/2006 - 08/2005
1	Chronic Disease (Chronic Diseases) 10/2022
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 11/2021
1	End Stage Liver Disease 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Autoimmune Hepatitis 01/2021
1	Varicose Veins (Varicose Vein) 01/2021
1	Disease Progression 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Cicatrix (Scar) 01/2020
1	Hepatitis B 03/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Weight Gain 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Hepatitis 01/2016
1	Chronic Hepatitis B 01/2016
1	Persistent Infection 01/2016

Drug/Important Bio-Agent (IBA)

7	Ribavirin (Virazole)FDA LinkGeneric 01/2016 - 11/2011
5	selonsertibIBA 01/2022 - 11/2019
4	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2006
4	Antiviral Agents (Antivirals)IBA 01/2022 - 04/2011
4	InterferonsIBA 03/2015 - 11/2011
3	AmmoniaIBA 01/2022 - 09/2006
3	Pharmaceutical PreparationsIBA 01/2021 - 08/2005
3	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 11/2011
3	Glucose (Dextrose)FDA LinkGeneric 03/2016 - 08/2015
2	very low density lipoprotein triglycerideIBA 10/2022 - 01/2020
2	EnzymesIBA 10/2022 - 01/2016
2	AlbuminsIBA 01/2022 - 01/2021
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 07/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 05/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2017
2	BilirubinIBA 01/2021 - 08/2005
2	NitrogenIBA 01/2020 - 05/2009
2	GlutaminaseIBA 01/2020 - 04/2006
2	LipidsIBA 01/2016 - 01/2016
1	Phospholipases (Phospholipase)IBA 10/2022
1	CollagenIBA 01/2022
1	simtuzumabIBA 01/2022
1	Fenofibrate (CiL)FDA LinkGeneric 11/2021
1	Fibric Acids (Fibrates)IBA 11/2021
1	obeticholic acidIBA 11/2021
1	BezafibrateIBA 11/2021
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 11/2021
1	Karyopherins (Importin)IBA 08/2021
1	fibroblast growth factor 21IBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	Cytidine Triphosphate (CTP)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Serum AlbuminIBA 11/2020
1	lardIBA 01/2020
1	MAP Kinase Kinase Kinase 5IBA 01/2020
1	Olive OilIBA 01/2020
1	Biological ProductsIBA 01/2019
1	Unsaturated FatsIBA 01/2019
1	micaIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	CarbohydratesIBA 01/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2017
1	Genetic Markers (Genetic Marker)IBA 02/2016
1	CreatinineIBA 01/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016
1	KIR ReceptorsIBA 01/2016
1	2- (2,6- dimethyl- 4- (3- (4- (methylthio)phenyl)- 3- oxo- 1- propenyl)phenoxyl)- 2- methylpropanoic acidIBA 01/2016
1	microsomal triglyceride transfer proteinIBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	nasIBA 08/2015
1	hydroxide ionIBA 07/2015
1	Alkaline PhosphataseIBA 07/2015

Therapy/Procedure

13	Therapeutics 10/2022 - 09/2006
7	Liver Transplantation 12/2020 - 08/2005
2	Transplantation 01/2018 - 08/2005
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2021
1	Antibiotic Prophylaxis 01/2021
1	Mediterranean Diet 01/2020